3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
8
Neoplasms
7
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Skin Neoplasms
2
Neoplastic Cells, Circulating
2
Lung Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
von Hippel-Lindau Disease
1
Weight Loss
1
Uterine Cervical Neoplasms
1
Sleep Apnea Syndromes
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Ovarian Insufficiency
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Nervous System Diseases
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Interventions
fludarabine
5
fludarabine phosphate
4
Cyclophosphamide
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
Surveys and Questionnaires
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Immune System Diseases
×
Blood Specimen Collection
×
Clear all
NCT06002945
2024-12-10
EXPLORE-MG2
Yale University
Active not recruiting
400 enrolled